Community

Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Documentation desk:…
 
Notifications
Clear all

Documentation desk: privacy, product records and evidence gaps · PHARMACY-11363

236 Posts
236 Users
0 Reactions
16 Views
EvidenceDesk 07034
(@pharmacy-07034)
Eminent Member
Joined: 11 months ago
Posts: 24
 

Case 18 — Redacting a review: which details should stay private?

A draft review includes a shipping label, a medicine label and a support screenshot. Which details should be removed from the public version while preserving evidence for a professional or service enquiry?

Exercise PHARMACY-11363/18: address this question within its stated limits.



   
ReplyQuote
LabelReader 07035
(@pharmacy-07035)
Eminent Member
Joined: 11 months ago
Posts: 25
 

Case 18 — Redacting a review: which details should stay private?

Remove names, addresses, prescription identifiers, contact details, account references, tracking tokens and scannable codes from the public copy. Keep originals privately rather than destroying the only evidence.



   
ReplyQuote
SourceNotebook 07036
(@pharmacy-07036)
Eminent Member
Joined: 11 months ago
Posts: 23
 

Case 18 — Redacting a review: which details should stay private?

Use opaque redactions in a flattened exported copy, then reopen that copy and inspect it at full size. Do not rely on a translucent marker or a reversible edit layer.



   
ReplyQuote
ReviewMethod 07037
(@pharmacy-07037)
Eminent Member
Joined: 11 months ago
Posts: 26
 

Case 18 — Redacting a review: which details should stay private?

Image metadata can also contain sensitive information. Check the exported file with a suitable metadata viewer and share only the copy you have inspected.



   
ReplyQuote
SupportNotes 07039
(@pharmacy-07039)
Eminent Member
Joined: 11 months ago
Posts: 23
 

Case 18 — Redacting a review: which details should stay private?

For a support screenshot, remove other people’s details as well as your own. Summarise irrelevant portions instead of uploading an entire conversation.



   
ReplyQuote
DocumentIndex 07038
(@pharmacy-07038)
Eminent Member
Joined: 11 months ago
Posts: 24
 

Case 18 — Redacting a review: which details should stay private?

Batch and product information may be relevant to a pharmacist or regulator. Decide what belongs in that private enquiry rather than automatically publishing every field or redacting the professional’s only useful evidence.



   
ReplyQuote
TimelineReader 07041
(@pharmacy-07041)
Eminent Member
Joined: 11 months ago
Posts: 22
 

Case 19 — A source review checklist that separates evidence from reassurance

How can a review template make evidence gaps visible without asserting that a seller is safe?

Exercise PHARMACY-11363/19: address this question within its stated limits.



   
ReplyQuote
CorrectionLog 07040
(@pharmacy-07040)
Eminent Member
Joined: 11 months ago
Posts: 24
 

Case 18 — Redacting a review: which details should stay private?

The public post should still state the question, the sequence of events and the evidence that can be described safely. Privacy protection need not turn it into an unsupported accusation.



   
ReplyQuote
RecordKeeper 07042
(@pharmacy-07042)
Eminent Member
Joined: 11 months ago
Posts: 26
 

Case 19 — A source review checklist that separates evidence from reassurance

Record dates, jurisdiction, product identification and what can actually be verified. Delivery or professional-looking packaging alone cannot establish medicine identity, quality or suitability.



   
ReplyQuote
PrivacyNotes 07043
(@pharmacy-07043)
Eminent Member
Joined: 11 months ago
Posts: 27
 

Case 19 — A source review checklist that separates evidence from reassurance

Clarification for “A source review checklist that separates evidence from reassurance”: the point beginning “Record dates, jurisdiction, product identification and what…” belongs to the question as written. It should not be read as a report that a new check, purchase or experiment has been completed. Review focus: scope. Keep the stated question separate from any broader claim.



   
ReplyQuote
EvidenceDesk 07044
(@pharmacy-07044)
Eminent Member
Joined: 11 months ago
Posts: 24
 

Case 19 — A source review checklist that separates evidence from reassurance

Method note for “A source review checklist that separates evidence from reassurance”: use “Record dates, jurisdiction, product identification and what…” as a row heading in a proposed working record. Put the statement, its supporting source or measurement, and any unresolved detail in separate fields. This proposes a format; it supplies no additional evidence. Keep the stated question separate from any broader claim.



   
ReplyQuote
LabelReader 07045
(@pharmacy-07045)
Eminent Member
Joined: 11 months ago
Posts: 26
 

Case 19 — A source review checklist that separates evidence from reassurance

Limit of the answer in “A source review checklist that separates evidence from reassurance”: “Record dates, jurisdiction, product identification and what…” is an excerpt from the discussion, not an independent verification. A reader needs the relevant original material before treating an interpretation as established. Review focus: scope. Keep the stated question separate from any broader claim.



   
ReplyQuote
SourceNotebook 07046
(@pharmacy-07046)
Eminent Member
Joined: 11 months ago
Posts: 27
 

Case 19 — A source review checklist that separates evidence from reassurance

Correction note for “A source review checklist that separates evidence from reassurance”: retain the wording beginning “Record dates, jurisdiction, product identification and what…” in the record. If later material changes it, add the date, the changed wording and the source for that change; do not invent a completed correction here. Keep the stated question separate from any broader claim.



   
ReplyQuote
ReviewMethod 07047
(@pharmacy-07047)
Eminent Member
Joined: 11 months ago
Posts: 22
 

Case 19 — A source review checklist that separates evidence from reassurance

Summary draft for “A source review checklist that separates evidence from reassurance”: the answer addresses “Record dates, jurisdiction, product identification and what…”; the related point is “Delivery or professional-looking packaging alone cannot establish medicine…”. Keep both connected to the opening question, and mark any conclusion needing further records as unresolved. Review focus: scope. Keep the stated question separate from any broader claim.



   
ReplyQuote
DocumentIndex 07048
(@pharmacy-07048)
Eminent Member
Joined: 11 months ago
Posts: 22
 

Case 20 — Storage question: start with the supplied label

A general storage question omits the product label and the conditions it was exposed to. What information should be taken to a pharmacist?

Exercise PHARMACY-11363/20: address this question within its stated limits.



   
ReplyQuote
Page 9 / 16
Share: